Single nucleotide polymorphism array analysis of microsatellite-stable, diploid/near-diploid colorectal carcinomas without the CpG island methylator phenotype

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 173-178

  Linnebacher, Michael ^a   Ostwald, Christiane ^a   Koczan, Dirk ^a   Salem, Tareq ^a   Schneider, Björn ^a   Krohn, Mathias ^a   Ernst, Mathias ^a   Prall, Friedrich ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Colorectal carcinoma; Loss of heterozygosity; SNP array

Indexed keywords

DNA;

ALLELE; ARTICLE; CHROMOSOME DELETION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DIPLOIDY; GENE AMPLIFICATION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY; UNIPARENTAL DISOMY;

EID: 84869043552     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1006     Document Type: Article

References (18)

1. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998.
2. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
3. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
4. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, Laird PW, Loda M and Fuchs CS: CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55: 1000-1006, 2006.
5. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130, 2007.
6. Ostwald C, Linnebacher M, Weirich V and Prall F: Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Int J Oncol 35: 321-327, 2009.
7. Gaasenbeek M, Howarth K, Rowan AJ, Gorman PA, Jones A, Chaplin T, Liu Y, Bicknell D, Davison EJ, Fiegler H, Carter NP, et al: Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 66: 3471-3479, 2006.
8. Andersen CL, Wiuf C, Kruhøffer M, Korsgaard M, Laurberg S and Ørntoft TF: Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis 28: 38-48, 2007.
9. Linnebacher M, Maletzki C, Ostwald C, Klier U, Krohn M, Klar E and Prall F: Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer 10: 362-371, 2010.
10. Prall F, Weirich V and Ostwald C: Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC) gene. Histopathology 50: 318-330, 2007.
11. Tomlison IPM, Lambros MBK and Roylance RR: Loss of heterozygosity analysis: Practically and conceptually flawed? Genes Chromosomes Cancer 34: 349-353, 2002.
12. Devilee P, Cleton-Jansen AM and Cornelisse CJ: Ever since Knudson. Trends in Genet 17: 569-573, 2001.
13. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, et al: The genomic landscapes of human colorectal breast and colorectal cancers. Science 318: 1108-1113, 2007.
14. Andersen CL, Lamy P, Thorsen K, Kjeldsen E, Wikman F, Villesen P, Oster B, Laurberg S and Orntoft TF: Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer 129: 1848-1858, 2011.
15. Wierzbicki PM, Adrych K, Kartanowicz D, Dobrowolski S, Stanislawowski M, Chybicki J, Godlewski J, Korybalski B, Smoczynski M and Kmiec Z: Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer. J Physiol Pharmacol S4: 63-70, 2009.
16. Bradley WE, Raelson JV, Dubois DY, Godin E, Fournier H, PrivéC, Allard R, Pinchuk V, Lapalme M, Paulussen RJ and Belouchi A: Hotspots of large rare deletions in the human genome. PloS One5: e9401, 2010.
17. Mitelman F, Johansson B and Mertens F: The impact of translocations and gene fusions on cancer causation. Nature Rev Cancer7: 233-245, 2007.
18. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K, Sougnez C, Voet D, Saksena G, Sivachenko A, Jing R, et al: Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nature Genetics43: 964-968, 2011.